缅甸基本非传染性疾病干预包(PEN)试点实施经验(2017-18):一项混合方法研究

缅甸PEN项目试点实施混合方法研究数据,包含非传染性疾病筛查、随访及卫生设施评估的定量和定性信息。

Figshare
2020-02-18 更新
浏览 28
多模态May 2017- December 2018CVD risk assessmentWorld Health Organizationpatient dataCVD riskhealth care staffblood sugar i.eCardiovascular Diseaseobjectives MyanmarConclusion High lossblood sugar measurementfollow-up visits
Experiences from the pilot implementation of the Package of Essential Non-communicable Disease Interventions (PEN) in Myanmar, 2017-18: A mixed methods study

基本信息

模态
多模态
大小
0.000081328 GB
许可
CC BY 4.0
创建/更新时间
2020-02-18
版本
v1

资源简介

缅甸基本非传染性疾病干预包(PEN)试点实施经验(2017-18):一项混合方法研究

【数据集背景】

本数据集源站标题为《Experiences from the pilot implementation of the Package of Essential Non-communicable Disease Interventions (PEN) in Myanmar, 2017-18: A mixed methods study》。配套论文《Experiences from the pilot implementation of the Package of Essential Non-communicable Disease Interventions (PEN) in Myanmar, 2017-18: A mixed methods study》发表于 PLOS ONE(2020),DOI:10.1371/journal.pone.0229081。源站首次发布:2020-02-18。

【数据内容】

源站原始描述:Background and objectives Myanmar adopted the World Health Organization (WHO) Package for Essential Non-Communicable Disease Interventions (PEN) in 20 pilot townships in 2017. This study was conducted to assess the implementation of PEN, its effectiveness and understand the facilitators and barriers in its implementation. Methods Mixed methods design involving a quantitative component (retrospective study analysing both aggregate and individual patient data from PEN project records; cross-sectio…

【数据结构与技术规格】

文件数 2 个,合计 81.33 KB。pone.0229081.s001.doc:application/msword,61.95 KB。pone.0229081.s002.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,19.38 KB。数据集 DOI:10.1371/journal.pone.0229081。

【主题与分类】

源站学科分类:Biochemistry、Medicine、Cell Biology、Pharmacology、Biotechnology、Marine Biology。主题标签:May 2017- December 2018、CVD risk assessment、World Health Organization、patient data、CVD risk、health care staff、blood sugar i.e、Cardiovascular Disease、objectives Myanmar、Conclusion High loss。

【适用方向】

多模态数据适合跨模态对齐、融合建模与联合表征学习方向的研究。

【获取与许可】

源站页面:https://plos.figshare.com/articles/dataset/Experiences_from_the_pilot_implementation_of_the_Package_of_Essential_Non-communicable_Disease_Interventions_PEN_in_Myanmar_2017-18_A_mixed_methods_study/11867235

使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。

规范引用:Aye, Lwin Lwin; Tripathy, Jaya Prasad; Maung, Thae Maung; Oo, Myo Minn; Nwe, Mya Lay; Thu, Hlaing Moh Moh; et al. (2020). Experiences from the pilot implementation of the Package of Essential Non-communicable Disease Interventions (PEN) in Myanmar, 2017-18: A mixed methods study. PLOS ONE. Dataset

【使用注意】

· 源站最后修改于 2023-05-31,引用时请注意版本时效。

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务(收技术服务费,非数据销售)

暂未开放

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "pone.0229081.s001.doc" "https://ndownloader.figshare.com/files/21751317"
curl -L -o "pone.0229081.s002.docx" "https://ndownloader.figshare.com/files/21751320"

文件清单

  • pone.0229081.s001.doc(61.95 KB)
  • pone.0229081.s002.docx(19.38 KB)

文件总体积 81.33 KB(源站 API 实测)。

数据加载示例(图像类)

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Background and objectives
Myanmar adopted the World Health Organization (WHO) Package for Essential Non-Communicable Disease Interventions (PEN) in 20 pilot townships in 2017. This study was conducted to assess the implementation of PEN, its effectiveness and understand the facilitators and barriers in its implementation.
Methods
Mixed methods design involving a quantitative component (retrospective study analysing both aggregate and individual patient data from PEN project records; cross-sectional facility survey using a structured checklist) and a descriptive qualitative component.
Results
A total of 152,446 individuals were screened between May 2017-December 2018 comprising of current smokers (17.5%), tobacco chewers (26.3%), Body Mass Index ≥25 kg/m2 (30.6%), raised blood pressure i.e. ≥ 140/90 mmHg (35.2%) and raised blood sugar i.e. Random Blood Sugar >200 mg/dl, Fasting Blood Sugar >126 mg/dl (17.1%). Nearly 14.8% of those screened had Cardiovascular Disease (CVD) risk score ≥20%, 34.6% had CVD risk not recorded. Of 663 patients registered with diabetes and/or hypertension in 05 townships, 27 (4.1%) patients made three follow-up visits after the baseline visit, of whom, CVD risk assessment, systolic blood pressure and blood sugar measurement was done in all visits in 89.0%, 100.0% and 78.0% of cases respectively. Health facility assessment showed 64% of the sanctioned posts were filled; 90% of those appointed been trained in PEN; key essential medicines for PEN were available in half of the facilities surveyed. Confidence of the health care staff in managing common NCD and perceived benefits of the project were some of the strengths.
Conclusion
High loss to follow up, poor recording of CVD risk score, lack of essential medicines and equipments were the key challenges identified that need to be addressed before further expansion of PEN project to other townships.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.1371/journal.pone.0229081(source: https://plos.figshare.com/articles/dataset/Experiences_from_the_pilot_implementation_of_the_Package_of_Essential_Non-communicable_Disease_Interventions_PEN_in_Myanmar_2017-18_A_mixed_methods_study/11867235)。

数据缺失?

依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。

⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。

获取专属数据定制方案